参考文献:
[1] 杨艺,孟宪生.消化性溃疡的研究进展[J].世界中医药,2017,12(4): 951-955.
[1] FarhadkhaniM, NikaeenM, HassanzadehA, et al. Potential transmission sources of Helicobacter pyloriinfection: detection of H. pylori in various environmental samples[J]. J Environ Health Sci Eng, 2019,17(1): 129–134. DOI: 10.1007/s40201-018-00333-y.
[2] ZamaniM, EbrahimtabarF, ZamaniV, et al. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection[J]. Aliment Pharmacol Ther, 2018, 47(7):868–876. DOI:10.1111/apt.14561.
[3] SerranoCA, PierreR, Van Der PolWJ, et al. Eradication of Helicobacter pylori in children restores the structure of the gastric bacterial community to that of noninfected children[J]. Gastroenterology,2019, 157(6): 1673–1675. DOI: 10.1053/j.gastro.2019.08.017.
[4] YangL, ZhangJ, XuJ, et al. Helicobacter pylori infection aggravates dysbiosis of gut microbiome in children with gastritis[J]. Front Cell Infect Microbiol, 2019, 9: 375. DOI: 10.3389/fcimb.2019.00375.
[5] ChuaEG, ChongJY, LamichhaneB, et al. Gastric Helicobacter pylori infection perturbs human oral microbiota[J]. PeerJ, 2019,7:e6336. DOI: 10.7717/peerj.6336.
[6] ZhaoY, GaoX, GuoJ, et al. Helicobacter pylori infection alters gastric and tongue coating microbial communities[J]. Helicobacter, 2019,24(2):e12567. DOI: 10.1111/hel.12567.
[7] PereiraV, AbrahamP, NallapetaS, et al. Gastric bacterial Flora in patients Harbouring Helicobacter pylori with or without chronic dyspepsia: analysis with matrix-assisted laser desorption ionization time-of-flight mass spectroscopy[J]. BMC Gastroenterol, 2018, 18(1): 20. DOI: 10.1186/s12876-018-0744-8.
[8] DashNR, KhoderG, NadaAM, et al. Exploring the impact of Helicobacter pylori on gut microbiome composition[J]. PLoS One, 2019, 14(6): e0218274.
DOI: 10.1371/journal.pone.0218274.
[9] OsakiT, ZamanC, YonezawaH, et al. Influence of intestinal indigenous microbiota on intrafamilial infection by Helicobacter pylori in Japan[J]. Front Immunol, 2018, 9: 287. DOI:10.3389/fimmu.2018.00287.
[10]
余莉,李红,王思平.基于高通量测序技术研究老年人肠道菌群结构变化[J].胃肠病学,2019,24(9):517-523.DOI:10.3969/j.issn.1008-7125.2019.09.002.
[11] DasA, PereiraV, SaxenaS, et al. Gastric microbiome of Indian patients with Helicobacter pyloriinfection, and their interaction networks[J]. Sci Rep, 2017, 7(1): 15438. DOI: 10.1038/s41598-017-15510-6.
[12] IinoC, ShimoyamaT, ChindaD, et al. Infection of Helicobacter pylori and atrophic gastritis influence lactobacillus in gut microbiota in a Japanese population[J]. Front Immunol, 2018,9:712. DOI:10.3389/fimmu.2018.00712.
[13] ItskovizD, BoltinD, LeibovitzhH, et al. Smoking increases the likelihood of Helicobacter pyloritreatment failure[J]. Dig Liver Dis, 2017, 49(7): 764–768. DOI: 10.1016/j.dld.2017.03.010.
[14] TsudaA, SudaW, MoritaH, et al. Influence of proton-pump inhibitors on the luminal microbiota in the gastrointestinal tract[J]. Clin Transl Gastroenterol, 2015,6:e89. DOI: 10.1038/ctg.2015.20.
[15] LiouJM, ChenCC, ChangCM, et al. Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial[J]. Lancet Infect Dis, 2019,19(10):1109–1120. DOI: 10.1016/S1473-3099(19)30272-5.
[16] Dávila-ColladoR, Jarquín-DuránO, DongLT, et al. Epstein-Barr virus and Helicobacter pylori co-infection in non-malignant gastroduodenal disorders[J]. Pathogens, 2020,9(2):104.DOI:10.3390/pathogens9020104.
[17] MassarratS, SanieeP, SiavoshiF, et al. The effect of Helicobacter pylori infection, aging, and consumption of proton pump inhibitor on fungal colonization in the stomach of dyspeptic patients[J]. Front Microbiol, 2016, 7: 801. DOI: 10.3389/fmicb.2016.00801.
[18] 曾冉冉,吴丽丽,张晓梅,等.微生态制剂对幽门螺杆菌感染的治疗作用[J].中华医学杂志,2015,95(16):1266–1267.DOI:10.3760/cma.j.issn.0376-2491.2015.16.020.
[19] BoyanovaL, GergovaG, MarkovskaR, et al. Bacteriocin-like inhibitory activities of seven Lactobacillus delbrueckii subsp. bulgaricus strains against antibiotic susceptible and resistant Helicobacter pylori strains[J]. Lett Appl Microbiol, 2017,65(6): 469–474. DOI: 10.1111/lam.12807.
[20] ZhaoK, XieQ, XuD, et al. Antagonistics of Lactobacillus plantarum ZDY2013 against Helicobacter pylori SS1 and its infection in vitro in human gastric epithelial AGS cells[J]. J Biosci Bioeng, 2018,126(4): 458–463. DOI: 10.1016/j.jbiosc.2018.04.003.
[21] ChenYH, TsaiWH, WuHY, et al. Probiotic lactobacillus spp. act against Helicobacter pylori-induced inflammation[J]. J Clin Med, 2019,8(1):90.DOI: 10.3390/jcm8010090.
[22] AliramaeiMR, KhorasganiMR, RahmaniMR, et al. Expression of Helicobacter pylori CagL gene in Lactococcus lactis MG1363 and evaluation of its immunogenicity as an oral vaccine in mice[J].Microb Pathog, 2019, 142: 103926. DOI: 10.1016/j.micpath.2019.103926.
[23] SunN, ZhangR, DuanG, et al. A food-grade engineered Lactococcus lactis strain deliveringHelicobacter pylori Lpp20 alleviates bacterial infection in H. pylori-challenged mice[J]. Biotechnol Lett, 2019, 41(12): 1415–1421. DOI: 10.1007/s10529-019-02740-z.
[24] WenJ, PengP, ChenP, et al. Probiotics in 14-day triple therapy for Asian pediatric patients withHelicobacter pylori infection: a network meta-analysis[J]. Oncotarget, 2017, 8(56): 96409–96418. DOI:10.18632/oncotarget.21633.
[25] DuYQ, SuT, FanJG, et al. Adjuvant probiotics improve the eradication effect of triple therapy forHelicobacter pylori infection[J]. World J Gastroenterol, 2012, 18(43): 6302–6307. DOI:10.3748/wjg.v18.i43.6302.
[26] World Gastroenterology Organisation. WGO Practice Guideline -Probiotics and Prebiotics[EB/OL]. (2017-0201).
https://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics.
[27] CárdenasPA, GarcésD, Prado-VivarB, et al. Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome[J]. Eur J Clin Microbiol Infect Dis, 2020,39(7):1365–1372. DOI: 10.1007/s10096-020-03854-3.
[28] ChangYW, ParkYM, OhCH, et al. Effects of probiotics or broccoli supplementation on Helicobacter pylori eradication with standard clarithromycin-based triple therapy[J]. Korean J Intern Med, 2020,35(3): 574–581. DOI: 10.3904/kjim.2019.139.
[29] 中华医学会老年医学分会《中华老年医学杂志》编辑委员会.肠道微生态制剂老年人临床应用中国专家共识(2019)[J].中华老年医学杂志,2019,38(4):355–361.DOI:10.3760/cma.j.issn.0254-9026.2019.04.002.
[30] 刘慧敏,韩怡,陆习婷.益生菌联合抗幽门螺杆菌治疗老年胃溃疡病人的临床疗效及对胃功能和肠道菌群的影响[J].实用老年医学,2020,34(2):121–124.DOI:10.3969/j.issn.1003-9198.2020.02.005.
[31] ZhouBG, ChenLX, LiB, et al. Saccharomyces boulardii as an adjuvant therapy for Helicobacter pylori eradication: a systematic review and meta-analysis with trial sequential analysis[J].Helicobacter, 2019, 24(5): e12651. DOI: 10.1111/hel.12651.
[32] 胡伏莲.难治性幽门螺杆菌感染处理原则和策略[J].中华医学杂志,2017,97(10):721–723.
[33] 高昳,王芳军,刘鹏飞,等.复方嗜酸乳杆菌片在提高首次根治失败的幽门螺杆菌感染的再次根治率中的作用[J].胃肠病学和肝病学杂志,2014,23(8):892–895.DOI:10.3969/j.issn.1006-5709.2014.08.013.
[34] LiuA, WangY, SongY, et al. Treatment with compound Lactobacillus acidophilus followed by a tetracycline-and furazolidone-containing quadruple regimen as a rescue therapy for Helicobacter pylori infection[J]. Saudi J Gastroenterol, 2020, 26(2): 78–83. DOI: 10.4103/sjg.SJG_589_19.